Postdoctoral Associate

Cancer Therapeutics and Immunology Postdoctoral Positions: Identifying New Therapeutic Targets in Lung Cancer.

Applications are invited for Postdoctoral Fellow positions in Hua Zhang's laboratory at the Department of Medicine, Division of Hematology/Oncology, Hillman Cancer Center of University of Pittsburgh Medical Center (UPMC). Pittsburgh is America's most livable city with a friendly and safe environment ). The University of Pittsburgh attracts students, fellows and faculty from around the world. Here, you can engage with colleagues from different countries and cultural backgrounds, fostering cross-cultural understanding and communication skills.

UPMC Hillman Cancer Center (Hillman) is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center - one of only 53 in the U.S. At UPMC Hillman Cancer Center, our researchers collaborate with our clinician-scientists to advance the most promising laboratory studies into novel clinical trials in order to provide patients with early access to new and innovative treatments. The nationally and internationally renowned research at UPMC Hillman Cancer Center includes a range of disciplines, from cancer prevention and early detection to novel therapeutic discovery, survivorship, and end-of-life care. We are also dedicated to the education and training of the next generation of cancer researchers and physicians, as well as the ongoing recruitment of world-renowned scientists. UPMC Hillman Cancer Center is the only NCI-designated Comprehensive Cancer Center in western Pennsylvania. We are dedicated to excellence for our patients, and we are working to make vast strides in the global effort to reduce the burden of cancer.

The Zhang lab develops the most advanced mouse models for lung cancer immunotherapy. The main research focuses of the Zhang's lab are:

1. establishing new immunocompetent mouse models for lung cancer and utilizing them to study the therapeutic efficacy and mechanisms of novel combination of targeted therapy with immunotherapy
2. identifying new therapeutic vulnerabilities to overcome drug resistance in lung cancer
3. characterizing the organ-specific tumor immune contexture to develop immunotherapeutic strategies

Our recent publications:

1. Cancer Cell, Journal for ImmunoTherapy of Cancer, Cancer Discovery, Clinical Cancer Research, 2020.

For other publications, pease see link below:

We seek applicants who are self-motivated and career-oriented to join an exciting and highly interactive research team. Candidates from all backgrounds with a Ph.D. or M.D. in medicine, biological science and research experience in areas related to cell, or molecular biology, genetics, biochemistry, immunology, mouse modeling are encouraged to contact Hua Zhang (M.D., Ph.D.), via email commensurate with research experience, according to the NIH intramural pay scale.